Premium
LB Pharmaceuticals Inc (LBRX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Deep Track Capital, LP | Institution | 3 352 804 | 11,69% | US$ 113,12M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 2 686 138 | 9,37% | US$ 90,63M | 2026-02-06 |
| RA Capital Management, L.P. | Institution | 2 208 604 | 7,70% | US$ 74,52M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 1 839 489 | 6,41% | US$ 62,06M | 2026-03-31 |
| TCG Crossover Fund II, L.P. | Institution | 1 839 489 | 6,41% | US$ 62,06M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 1 675 000 | 5,84% | US$ 56,51M | 2025-09-12 |
| Commodore Capital LP | Institution | 1 500 000 | 5,23% | US$ 50,61M | 2026-03-31 |
| Caligan Partners, LP | Institution | 1 438 070 | 5,01% | US$ 48,52M | 2026-03-31 |
| Pontifax Venture Capital | Institution | 1 411 681 | 4,92% | US$ 47,63M | 2026-03-31 |
| JP Morgan Asset Management | Institution | 1 392 004 | 4,85% | US$ 46,97M | 2026-03-31 |
| Spruce Street Capital LP | Institution | 1 376 159 | 4,80% | US$ 46,43M | 2026-03-31 |
| Trails Edge Capital Partners, LP | Institution | 1 319 362 | 4,60% | US$ 44,52M | 2026-03-31 |
| Commodore Capital Master LP | Institution | 1 225 000 | 4,27% | US$ 41,33M | 2025-09-11 |
| Nantahala Capital Management, LLC | Institution | 1 052 894 | 3,67% | US$ 35,52M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 923 694 | 3,22% | US$ 31,17M | 2026-03-31 |
| Logos Global Management, L.P. | Institution | 915 000 | 3,19% | US$ 30,87M | 2026-03-31 |
| Vida Ventures Advisors, LLC | Institution | 882 243 | 3,08% | US$ 29,77M | 2025-09-12 |
| Vida Ventures III, L.P. | Institution | 882 243 | 3,08% | US$ 29,77M | 2025-09-12 |
| Alyeska Investment Group, L.P. | Institution | 863 947 | 3,01% | US$ 29,15M | 2026-03-31 |
| Vivo Capital, LLC | Institution | 800 000 | 2,79% | US$ 26,99M | 2026-03-31 |
| Pivotal BioVenture Partners LLC | Institution | 630 657 | 2,20% | US$ 21,28M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 518 228 | 1,81% | US$ 17,49M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 363 799 | 1,27% | US$ 12,27M | 2026-03-31 |
| Great Point Partners, LLC | Institution | 300 000 | 1,05% | US$ 10,12M | 2026-03-31 |
| Baker Bros. Advisors LP | Institution | 200 000 | 0,70% | US$ 6,75M | 2026-03-31 |
| HighVista Strategies LLC | Institution | 173 595 | 0,61% | US$ 5,86M | 2026-03-31 |
| Calamos Advisors LLC | Institution | 157 655 | 0,55% | US$ 5,32M | 2026-04-30 |
| PGIM Securities Investment Trust Enterprise | Institution | 151 417 | 0,53% | US$ 5,11M | 2026-03-31 |
| Integral Health Asset Management, LLC | Institution | 150 000 | 0,52% | US$ 5,06M | 2026-03-31 |
| UBS Asset Management AG | Institution | 137 932 | 0,48% | US$ 4,65M | 2026-03-31 |
| Millennium Management LLC | Institution | 136 966 | 0,48% | US$ 4,62M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 112 497 | 0,39% | US$ 3,80M | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | Institution | 108 307 | 0,38% | US$ 3,65M | 2026-03-31 |
| Eversept Partners, L.P. | Institution | 100 198 | 0,35% | US$ 3,38M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
